+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Development of specific antisera and a radioimmunoassay procedure for the gonadotropin releasing hormone associated peptide of the lhrh prohormone



Development of specific antisera and a radioimmunoassay procedure for the gonadotropin releasing hormone associated peptide of the lhrh prohormone



Brain Research Bulletin 17(2): 219-224



Recently, the structure of the cDNAs encoding the human and rat LHRH prohormones were determined and the corresponding peptide sequences deduced. In addition to LHRH, both cDNAs encoded a 56 amino acid sequence which has been designated gonadotropin-releasing hormone associated peptide (GAP). In order to initiate studies on the LHRH prohormone, three antisera (MC-1, MC-2 and MC-3) were generated using the human GAP (hGAP) 25-53 fragment as immunogen and a corresponding radioimmunoassay procedure was developed. The binding of 125I-labeled hGAP 1-56 to all three antisera was displaced completely by unlabeled hGAP 1-56. Acid extracts of rat median eminence produced displacement curves that were parallel to the hGAP 1-56 curve. Conversely, extracts of rat cortex and a number of brain and pituitary peptides, including LHRH nad LHRH analogs, did not affect tracer binding. Several fragments of the human and rat GAP (rGAP) sequences (hGAP 25-53, hGAP 27-40 and rGAP 20-43) produced tracer displacement curves that were non-parallel with the hGAP 1-56 curve and/or gave only incomplete tracer displacement when all three antisera were tested. This suggests that the antisera contain multiple antibody populations directed toward several different antigenic determinants within the mid portion of the hGAP and rGAP sequences. The rGAP fragments, rGAP 1-11 and rGAP 39-53, failed to displace the tracer, further supporting that the antigenic sites occur within the mid portion of the rGAP sequence. Co-existence of radioimmunoassayable LHRH and GAP-like immunoreactivity (using MC-2 antiserum) was demonstrated in extracts of brain regions containing LHRH cell bodies, fibres and termini (preoptic area, hypothalamus, and median eminence). Radioimmunoassays employing these antisera, in conjunction with radioimmunoassays for LHRH, will be useful for studies of LHRH-prohormone localization, synthesis and processing under various physiologic and pathologic conditions.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005135429

Download citation: RISBibTeXText


Related references

Development of specific antisera and a radioimmunoassay procedure for the gonadotropin-releasing hormone associated peptide (GAP) of the LHRH prohormone. Brain Research Bulletin 17(2): 219-223, 1986

Gonadotropin releasing hormone associated peptide gap and luteinizing hormone releasing hormone lhrh are secreted as intact peptides from median eminence in response to different secretagogues in vitro. Society for Neuroscience Abstracts 13(1): 19, 1987

Effect of protein deficiency on luteinizing hormone releasing hormone (LHRH), gonadotropin releasing hormone associated peptide (GAP) and luteinizing hormone (LH) immunocytochemistry in the hypothalamus and pituitary gland of prepubertal ewes. Experimental and Clinical Endocrinology 101(4): 230-237, 1993

Behavioral interactions have rapid effects on immunoreactivity of prohormone and gonadotropin-releasing hormone peptide. Brain Research. 772(1-2): 87-94,. 24, 1997

Lhrh and gonadotropin releasing hormone associated peptide and the appearance of luteinizing hormone and fsh immunoreactivity in the rat anterior pituitary gland. Society for Neuroscience Abstracts 16(1): 397, 1990

Pulsatile gonadotropin hormone releasing hormone treatment for induction of ovulation radioimmunoassay of plasma gonadotropin releasing hormone administered intravenously and subcutaneously. Journal of Steroid Biochemistry 20(6 Part B): 1403, 1984

Search for peptide immunogens of the β-subunit of human chorionic gonadotropin (hCG) capable of eliciting hormone specific and neutralizing antisera : Identification of an undecapeptide eliciting hCG-specific antisera. Chemical Biology & Drug Design 39(2): 137-144, 1992

Search for peptide immunogens of the beta subunit of human chorionic gonadotropin hcg capable of eliciting hormone specific and neutralizing antisera identification of an undecapeptide eliciting hcg specific antisera. International Journal of Peptide & Protein Research 39(2): 137-144, 1992

Immunocytochemical Localization of the Gonadotropin-Releasing Hormone-Associated Peptide of the Lhrh Precursor. Neuroendocrinology 45(2): 172-175, 1987

Immunocytochemical localization of the gonadotropin-releasing hormone-associated peptide of the LHRH precursor. Neuroendocrinology 45(2): 172-175, 1987

Ontention of antisera against a hypothalamic decapeptide (luteinizing hormone/follicle stimulating hormone releasing hormone) which stimulates the release of pituitary gonadotropins and development of its radioimmunoassay. Biochimica et Biophysica Acta - General Subjects 297(2): 540-548, 1973

Obtention of antisera against a hypothalamic decapeptide (luteinizing hormone-follicle stimulating hormone releasing hormone) which stimulated the release of pituitary gonadotropins and development of its radioimmunoassay. Biochimica et Biophysica Acta 297(2): 540-548, 1973

Triton X-100 eliminates plasma proteins interference in a radioimmunoassay for luteinizing hormone-releasing hormone (LHRH) and LHRH analogues. Journal of Immunological Methods 122(2): 291-296, 1989

Radioimmunoassay for luteinizing hormone-releasing hormone (LHRH): its application to the measurement of LHRH in ovine and human plasma. Endocrinology 96(2): 384-393, 1975

Regulation of type II luteinizing hormone-releasing hormone (LHRH-II) gene expression by the processed peptide of LHRH-I, LHRH-(1-5) in endometrial cells. Experimental Biology and Medicine 232(1): 146-155, 2007